BioCentury
ARTICLE | Company News

Crucell, MASTA Ltd. sales and marketing update

October 5, 2009 7:00 AM UTC

Crucell acquired a sales team from U.K. commercial partner MASTA to market travel vaccines including Epaxal aluminum-free hepatitis A vaccine; Vivotif oral typhoid fever vaccine; and Dukoral oral vaccine against cholera and travelers' diarrhea. The sales team also will start marketing Crucell's virosomal adjuvanted seasonal influenza vaccine Inflexal V in 2010. Financial terms of the deal were not disclosed. ...